English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/38907
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells

AuthorsZanella, Fabian; Renner, Oliver; García, Beatriz; Callejas, S.; Dopazo, A.; Peregrina, Sandra; Carnero, Amancio ; Link, Wolfgang
KeywordsTRIB2
FOXO
Melanoma
RNAi
Screening
Issue Date8-Mar-2010
PublisherMacmillan Publishers
CitationOncogene 29: 2973-2982 (2010)
AbstractFOXO transcription factors are evolutionarily conserved proteins that orchestrate gene expression programs known to control a variety of cellular processes such as cell cycle, apoptosis, DNA repair and protection from oxidative stress. As the abrogation of FOXO function is a key feature of many tumor cells, regulation of FOXO factors is receiving increasing attention in cancer research. In order to discover genes involved in the regulation of FOXO activity, we performed a large-scale RNA-mediated interference (RNAi) screen using cell-based reporter systems that monitor transcriptional activity and subcellular localization of FOXO. We identified genes previously implicated in phosphoinositide 3-kinase/Akt signaling events, which are known to be important for FOXO function. In addition, we discovered a previously unrecognized FOXO-repressor function of TRIB2, the mammalian homolog of the Drosophila gene tribbles. A cancer-profiling array revealed specific overexpression of TRIB2 in malignant melanoma, but not in other types of skin cancer. We provide experimental evidence that TRIB2 transcript levels correlate with the degree of cytoplasmic localization of FOXO3a. Moreover, we show that TRIB2 is important in the maintenance of the oncogenic properties of melanoma cells, as its silencing reduces cell proliferation, colony formation and wound healing. Tumor growth was also substantially reduced upon RNAi-mediated TRIB2 knockdown in an in vivo melanoma xenograft model. Our studies suggest that TRIB2 provides the melanoma cells with growth and survival advantages through the abrogation of FOXO function. Altogether, our results show the potential of large-scale cell-based RNAi screens to identify promising diagnostic markers and therapeutic targets.
Description10 páginas, 6 figuras.
Publisher version (URL)http://dx.doi.org/10.1038/onc.2010.58
URIhttp://hdl.handle.net/10261/38907
DOI10.1038/onc.2010.58
ISSN0950-9232
E-ISSN1476-5594
Appears in Collections:(IBIS) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.